Log in
Enquire now
‌

US Patent 9801637 Genetically-associated chronic obstructive pulmonary disease treatment

Patent 9801637 was granted and assigned to PneumRx on October, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributors

Contents

Is a
Patent
Patent

Patent attributes

Patent Applicant
PneumRx
PneumRx
Current Assignee
PneumRx
PneumRx
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
9801637
Patent Inventor Names
Kara Andersen Reiter0
Mark L. Mathis0
Date of Patent
October 31, 2017
Patent Application Number
14525123
Date Filed
October 27, 2014
Patent Citations Received
‌
US Patent 11919856 Compounds
0
Patent Primary Examiner
‌
Ryan J. Severson
Patent abstract

A method for treating a genetically associated chronic obstructive pulmonary disease. At least one implant is advanced into an airway of a lung having a genetically associated chronic obstructive pulmonary disease. The at least one implant is delivered into the lung to increase tension of the lung and thereby improve breathing function of the lung.

Timeline

No Timeline data yet.

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more entities like US Patent 9801637 Genetically-associated chronic obstructive pulmonary disease treatment

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us